These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 14068079)

  • 1. LIPOATROPHIC DIABETES. ISOLATION AND CHARACTERIZATION OF AN INSULIN ANTAGONIST FROM URINE.
    LOUIS LH; CONN JW; MINICK MC
    Metabolism; 1963 Oct; 12():867-86. PubMed ID: 14068079
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoatrophic diabetes: an improved procedure for the isolation and purification of a diabetogenic polypeptide from urine.
    Louis LH
    Metabolism; 1969 Jul; 18(7):545-55. PubMed ID: 5788258
    [No Abstract]   [Full Text] [Related]  

  • 3. A diabetogenic polypeptide from hog and sheep adenohypophysis similar to that found in lipoatrophic diabetes.
    Louis LH; Conn JW
    Metabolism; 1968 Jun; 17(6):475-84. PubMed ID: 5651597
    [No Abstract]   [Full Text] [Related]  

  • 4. A diabetogenic polypeptide from bovine adenohypophysis similar to that excreted in lipoatrophic diabetes.
    Louis LH; Conn JW; Minick MC
    Metabolism; 1966 Apr; 15(4):309-24. PubMed ID: 4285865
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital generalized lipodystrophy and experimental lipoatrophic diabetes in rabbits treated successfully with fenfluramine.
    Trygstad O; Foss I
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):436-48. PubMed ID: 577333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIPOATROPHIC DIABETES. I. STUDIES CONCERNING ENDOCRINE FUNCTION AND CARBOHYDRATE METABOLISM.
    RUVALCABA RH; SAMOLS E; KELLEY VC
    Am J Dis Child; 1965 Apr; 109():279-86. PubMed ID: 14261005
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
    Haugaard SB; Andersen O; Vølund A; Hansen BR; Iversen J; Andersen UB; Nielsen JO; Madsbad S
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):354-61. PubMed ID: 15730419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SERUM INSULIN-LIKE ACTIVITY IN GENETIC AND EXPERIMENTAL DIABETES MELLITUS.
    POWER L; REYES-LEAL B; CONN JW
    Metabolism; 1964 Nov; 13():1297-309. PubMed ID: 14241220
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of hyperinsulinemia and hyperglycemia in dogs by administration of diabetogenic bovine pituitary peptide.
    Louis LH; Conn JW; Appelt MM
    Metabolism; 1971 Mar; 20(3):326-30. PubMed ID: 5546927
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
    Rajamand N; Ungerstedt U; Brismar K
    Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On a case of insulin lipodystrophy].
    da COSTA J
    Rev Iber Endocrinol; 1963; 10():81-7. PubMed ID: 14023267
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin in blood and urine.
    Fraser R
    Sci Basis Med Annu Rev; 1968; ():206-23. PubMed ID: 4875492
    [No Abstract]   [Full Text] [Related]  

  • 14. Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution.
    Haugaard SB; Andersen O; Halsall I; Iversen J; Hales CN; Madsbad S
    Metabolism; 2007 Jul; 56(7):939-46. PubMed ID: 17570256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance in a rural Maori community.
    Tipene-Leach D; Pahau H; Joseph N; Coppell K; McAuley K; Booker C; Williams S; Mann J
    N Z Med J; 2004 Dec; 117(1207):U1208. PubMed ID: 15608803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass.
    Takada J; Machado MA; Peres SB; Brito LC; Borges-Silva CN; Costa CE; Fonseca-Alaniz MH; Andreotti S; Lima FB
    Metabolism; 2007 Jul; 56(7):977-84. PubMed ID: 17570261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral glucose tolerance test in children and adolescents: positives and pitfalls.
    Conwell LS; Batch JA
    J Paediatr Child Health; 2004 Nov; 40(11):620-6. PubMed ID: 15469531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of oral glucose minimal model-derived index of insulin sensitivity in subjects with early type 1 diabetes mellitus.
    Krudys KM; Greenbaum CJ; Pihoker C; Vicini P
    Metabolism; 2008 Apr; 57(4):445-7. PubMed ID: 18328342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.